Cefclidin
Alternative Names: Cepock; E 1040Latest Information Update: 26 Jan 1995
At a glance
- Originator Eisai Co Ltd
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 26 Jan 1995 The approval application for cefclidin in Japan has been withdrawn
- 26 Jan 1995 Discontinued-preregistration for Bacterial infections in Japan (IV)
- 31 Oct 1992 Preregistration for Bacterial infections in Japan (IV)